These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31094300)

  • 1. Solubility enhancement effect at absorption site on bioavailability of ritonavir using liquisolid technique.
    Bonthagarala B; Dasari V; Kotra V
    Ther Deliv; 2019 May; 10(5):295-310. PubMed ID: 31094300
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigation of the effect of solubility increase at the main absorption site on bioavailability of BCS class II drug (risperidone) using liquisolid technique.
    Khames A
    Drug Deliv; 2017 Nov; 24(1):328-338. PubMed ID: 28165818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.
    Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS
    Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir.
    Sinha S; Ali M; Baboota S; Ahuja A; Kumar A; Ali J
    AAPS PharmSciTech; 2010 Jun; 11(2):518-27. PubMed ID: 20238187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid self-microemulsifying drug delivery system of ritonavir.
    Deshmukh A; Kulkarni S
    Drug Dev Ind Pharm; 2014 Apr; 40(4):477-87. PubMed ID: 23465049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of oral bioavailability of carvedilol by liquisolid compact: optimization and pharmacokinetic study.
    Jhaveri M; Nair AB; Shah J; Jacob S; Patel V; Mehta T
    Drug Deliv Transl Res; 2020 Aug; 10(4):975-985. PubMed ID: 32124413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
    Indulkar AS; Lou X; Zhang GGZ; Taylor LS
    Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.
    Desai C; Prabhakar B
    Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
    Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissolution enhancement of tadalafil by liquisolid technique.
    Lu M; Xing H; Yang T; Yu J; Yang Z; Sun Y; Ding P
    Pharm Dev Technol; 2017 Feb; 22(1):77-89. PubMed ID: 27268461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
    Sawant KK; Patel MH; Patel K
    Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation.
    Fahmy RH; Kassem MA
    Eur J Pharm Biopharm; 2008 Aug; 69(3):993-1003. PubMed ID: 18396390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of ketoconazole dissolution rate by the liquisolid technique.
    Molaei MA; Osouli-Bostanabad K; Adibkia K; Shokri J; Asnaashari S; Javadzadeh Y
    Acta Pharm; 2018 Sep; 68(3):325-336. PubMed ID: 31259692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of ketoprofen dissolution rate by the liquisolid technique: optimization and in vitro and in vivo investigations.
    Devi S; Kumar S; Verma V; Kaushik D; Verma R; Bhatia M
    Drug Deliv Transl Res; 2022 Nov; 12(11):2693-2707. PubMed ID: 35178670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabrication, solid state characterization and bioavailability assessment of stable binary amorphous phases of Ritonavir with Quercetin.
    Dengale SJ; Hussen SS; Krishna BS; Musmade PB; Gautham Shenoy G; Bhat K
    Eur J Pharm Biopharm; 2015 Jan; 89():329-38. PubMed ID: 25542681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation of physicochemical properties of piroxicam liquisolid compacts.
    Javadzadeh Y; Siahi MR; Asnaashari S; Nokhodchi A
    Pharm Dev Technol; 2007; 12(3):337-43. PubMed ID: 17613897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin.
    Ibrahim AH; Smått JH; Govardhanam NP; Ibrahim HM; Ismael HR; Afouna MI; Samy AM; Rosenholm JM
    Eur J Pharm Sci; 2020 Jan; 142():105103. PubMed ID: 31648050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability enhancement of a BCS IV compound via an amorphous combination product containing ritonavir.
    Miller DA; Keen JM; Brough C; Ellenberger DJ; Cisneros M; Williams RO; McGinity JW
    J Pharm Pharmacol; 2016 May; 68(5):678-91. PubMed ID: 26454138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality by design approach for oral bioavailability enhancement of irbesartan by self-nanoemulsifying tablets.
    Patel J; Dhingani A; Garala K; Raval M; Sheth N
    Drug Deliv; 2014 Sep; 21(6):412-35. PubMed ID: 24215334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquisolid Technology: A State-of-the-Art Review on the Current State, Challenges, New and Emerging Technologies for Next Generation.
    Agiba AM
    Curr Drug Deliv; 2020; 17(9):736-754. PubMed ID: 32729418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.